The strong institutional buying cluster, particularly from active managers Blackstone and Verition, signals growing conviction in Lexeo's pipeline. Monitor for upcoming clinical catalysts or earnings that could validate this institutional thesis. The 45-day 13F reporting lag means positions may have already been adjusted.
Executive Summary
A cluster of 8 institutional buyers accumulated positions in Lexeo Therapeutics during Q3 2024, led by Blackstone (adding 353K shares) and Verition Fund Management (adding 356K shares), while only one trivial seller was present. The aggregate buying value of $18.7M suggests growing institutional conviction, though the net dollar change was slightly negative (-$2.1M) due to share price decline during the quarter.
Key Financial Metrics
Institutional Positions
Net institutional flow: -$2.1M
▲ Buyers (8)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Blackstone | ADD | +43.8% | $10.5M | -$2.5M |
| Verition Fund Management | ADD | +84.5% | $7.0M | $268.0K |
▼ Sellers (1)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Cwm | TRIM | -37.5% | $0.00 | $0.00 |
Key Facts
- 8 institutional buyers vs 1 seller in Q3 2024
- Blackstone added 352.9K shares (+43.8%), now holding ~1.16M shares
- Verition Fund Management added 355.9K shares (+84.5%), now holding ~777K shares
- Aggregate buyer holdings: $18.7M current value
- Only one seller (Cwm) trimmed 6 shares — negligible
- Cluster dominated by active asset managers (7 of 8), not passive index funds
Financial Impact
8 institutions accumulated positions totaling $18.7M in current value, with net dollar change of -$2.1M due to stock price decline during the quarter. Blackstone and Verition were the largest buyers by share count.
Risk Factors
- 13F data is 45+ days old — cluster may have been unwound
- Net dollar change was negative (-$2.1M) despite share increases, indicating price decline
- Pre-revenue biotech with binary clinical risk
- Small absolute dollar amounts ($18.7M aggregate) relative to typical institutional clusters
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-LXEO-2024-Q3 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 14d ago | SC 13G | $2.74 $3.02 | ▲ +10.22% | ▲ +11.37% | — |
Sep 22, 2026 5w ago | 8-K | $4.07 $3.42 | ▼ −15.97% | ▼ −14.78% | — |
Aug 12, 2026 10w ago | 8-K | $4.87 $5.37 | ▲ +10.27% | ▲ +10.71% | — |
Aug 12, 2026 10w ago | Press Release | $4.87 $5.37 | ▲ +10.27% | ▲ +10.71% | — |
Jul 1, 2026 16w ago | Insider Cluster | $4.69 $5.05 | ▲ +7.68% | ▲ +6.75% | — |
Jun 17, 2026 18w ago | Press Release | $4.93 $4.70 | ▼ −4.67% | ▼ −3.00% | — |
Jun 15, 2026 19w ago | 8-K | $4.65 $5.04 | ▲ +8.39% | ▲ +9.77% | — |
Jun 12, 2026 19w ago | Institutional Cluster | $4.37 $4.93 | ▲ +12.81% | ▲ +12.14% | — |
May 20, 2026 22w ago | Insider Cluster | $5.23 $5.14 | ▼ −1.72% | ▼ −3.57% | — |
May 11, 2026 24w ago | 8-K | $6.12 $4.71 | ▼ −23.04% | ▼ −22.95% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers